NDC 0143-9533

Allopurinol sodium

Allopurinol Sodium

Allopurinol sodium is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Allopurinol Sodium.

• Product ID: 0143-9533_0083505e-a473-4236-ac5d-c892d0c05158
• NDC: 0143-9533
• Product Type: Human Prescription Drug
• Proprietary Name: Allopurinol sodium
• Generic Name: Allopurinol Sodium
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2004-09-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA076870
• Labeler Name: Hikma Pharmaceuticals USA Inc.
• Substance Name: ALLOPURINOL SODIUM
• Active Ingredient Strength: 500 mg/25mL
• Pharm Classes: Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0143-9533-01

1 VIAL in 1 BOX, UNIT-DOSE (0143-9533-01) > 25 mL in 1 VIAL

• Marketing Start Date: 2004-09-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0143-9533-01 [00143953301]

Allopurinol sodium INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA076870
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2004-09-01

Drug Details

Active Ingredients

Ingredient	Strength
ALLOPURINOL SODIUM	500 mg/25mL

OpenFDA Data

• SPL SET ID: 9ae58f3c-dbf9-4c10-9b79-233b10e0e9f1
• Manufacturer:
  • West-Ward Pharmaceuticals Corp
• UNII:
  • 428673RC2Z
• RxNorm Concept Unique ID - RxCUI:
  • 252931

Pharmacological Class

• Xanthine Oxidase Inhibitor [EPC]
• Xanthine Oxidase Inhibitors [MoA]
• Xanthine Oxidase Inhibitor [EPC]
• Xanthine Oxidase Inhibitors [MoA]